-transparent.png){kind=logo}
A chemically stable carboprostacyclin analogue, ZK 36374 has been compared with two other prostacyclin derivatives with respect to ADP-induced in vitro aggregation of baboon and human platelets and ex vivo platelet aggregation in the baboon. ZK 36374 was also tested on the systemic arterial blood pressure of the baboon and against vasopressin-induced ECG changes in primates. Compared to the other two compounds, ZK 36374 displayed enhanced anti-platelet aggregating activity; there was dissociation between this property and its hypotensive potency. ZK 36374 antagonized the vasopressin-induced ECG changes. These results indicate that ZK 36374 possesses therapeutic potential in vascular disease including that affecting the coronary vessels.
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
May 1985,
British journal of haematology,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
March 1987,
British journal of haematology,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
January 1989,
European journal of nuclear medicine,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
August 2005,
Bulletin of experimental biology and medicine,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
January 1986,
Haemostasis,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
January 1985,
Acta haematologica,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
February 1985,
Thrombosis and haemostasis,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
July 1983,
Japanese heart journal,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
March 1988,
American heart journal,
P G Adaikan, and
S M Karim, and
L C Lau, and
M Y Tai, and
S R Kottegoda
October 1984,
Thrombosis research,
